Notable companies
The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX).
Industry description
The investment seeks to provide long-term growth of capital.
The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries.
Market Cap
The average market capitalization across the BlackRock Health Sciences Opps Inv C MF is 283.42B. The market cap for tickers in the group ranges from 67.78B to 987.23B. LLY holds the highest valuation in this group at 987.23B. The lowest valued company is BSX at 67.78B.
Volume
The average weekly volume growth across all stocks in the BlackRock Health Sciences Opps Inv C MF was -6%. For the same stocks of the MF, the average monthly volume growth was 15% and the average quarterly volume growth was 288%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 21
P/E Growth Rating: 52
Price Growth Rating: 48
SMR Rating: 44
Profit Risk Rating: 62
Seasonality Score: 19 (-100 ... +100)